Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, Gower C, Kall M, Groves N, O'Connell AM, Simons D, Blomquist PB, Zaidi A, Nash S, Iwani Binti Abdul Aziz N, Thelwall S, Dabrera G, Myers R, Amirthalingam G, Gharbia S, Barrett JC, Elson R, Ladhani SN, Ferguson N, Zambon M, Campbell CNJ, Brown K, Hopkins S, Chand M, Ramsay M, Lopez Bernal J. Andrews N, et al. Among authors: nash s. N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2. N Engl J Med. 2022. PMID: 35249272 Free PMC article.
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England.
Brown AE, Croxford SE, Nash S, Khawam J, Kirwan P, Kall M, Bradshaw D, Sabin C, Miller RF, Post FA, Harding R, Collins S, Waters L, Asboe D, Chadwick DR, Delpech V, Sullivan AK. Brown AE, et al. Among authors: nash s. HIV Med. 2022 Jan;23(1):90-102. doi: 10.1111/hiv.13167. Epub 2021 Sep 15. HIV Med. 2022. PMID: 34528739 Free PMC article.
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.
Nyberg T, Harman K, Zaidi A, Seaman SR, Andrews N, Nash SG, Charlett A, Lopez Bernal J, Myers R, Groves N, Gallagher E, Gharbia S, Chand M, Thelwall S, De Angelis D, Dabrera G, Presanis AM. Nyberg T, et al. Among authors: nash sg. J Infect Dis. 2022 Sep 13;226(5):808-811. doi: 10.1093/infdis/jiac063. J Infect Dis. 2022. PMID: 35184201 Free PMC article.
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, Hinsley W, Bernal JL, Kall M, Bhatt S, Blomquist P, Zaidi A, Volz E, Aziz NA, Harman K, Funk S, Abbott S; COVID-19 Genomics UK (COG-UK) consortium; Hope R, Charlett A, Chand M, Ghani AC, Seaman SR, Dabrera G, De Angelis D, Presanis AM, Thelwall S. Nyberg T, et al. Among authors: nash sg. Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16. Lancet. 2022. PMID: 35305296 Free PMC article.
Variation in reported SARS-CoV-2 cases after testing policy changes.
Halford F, Nash S, Tessier E, Kall M, Dabrera G. Halford F, et al. Among authors: nash s. Lancet Infect Dis. 2022 Oct;22(10):1418-1419. doi: 10.1016/S1473-3099(22)00572-2. Epub 2022 Aug 23. Lancet Infect Dis. 2022. PMID: 36027903 Free PMC article. No abstract available.
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
Allen H, Tessier E, Turner C, Anderson C, Blomquist P, Simons D, Løchen A, Jarvis CI, Groves N, Capelastegui F, Flannagan J, Zaidi A, Chen C, Rawlinson C, Hughes GJ, Chudasama D, Nash S, Thelwall S, Lopez-Bernal J, Dabrera G, Charlett A, Kall M, Lamagni T. Allen H, et al. Among authors: nash s. Epidemiol Infect. 2023 Mar 20;151:e58. doi: 10.1017/S0950268823000420. Epidemiol Infect. 2023. PMID: 36938806 Free PMC article.
Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with sotrovimab in the community in England.
Harman K, Nash SG, Webster HH, Groves N, Hardstaff J, Bridgen J, Blomquist PB, Hope R, Ashano E, Myers R, Rokadiya S, Hopkins S, Brown CS, Chand M, Dabrera G, Thelwall S. Harman K, et al. Among authors: nash sg. Influenza Other Respir Viruses. 2023 May;17(5):e13150. doi: 10.1111/irv.13150. Influenza Other Respir Viruses. 2023. PMID: 37246147 Free PMC article.
Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection.
Twohig KA, Harman K, Zaidi A, Aliabadi S, Nash SG, Sinnathamby M, Harrison I, Gallagher E, Groves N, Schwach F, Pearson C, Thornton A, Myers R, Chand M, Thelwall S, Dabrera G. Twohig KA, et al. Among authors: nash sg. Epidemiol Infect. 2023 Sep 20;151:e169. doi: 10.1017/S0950268823001541. Epidemiol Infect. 2023. PMID: 37726109 Free PMC article.
543 results